相关临床试验
1
1 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
尚未招募
1
100.0%
暂无批准数据
- India's drug regulator CDSCO revealed that 1,705 clinical trial participants died from serious adverse events between 2021 and July 2025, averaging one death per day. - An additional 7,189 non-fatal serious adverse events were recorded during the same period, affecting an average of 4.2 people daily with life-threatening side effects. - Only 68 families received compensation out of all 1,705 deaths, highlighting significant gaps in participant protection and accountability. - A recent case in Hyderabad exposed potential regulatory violations, including unregistered trials and inadequate medical care for participants experiencing adverse events.
- Ethniq has launched Skin Revive, a patented steroid-free treatment for chronic fungal skin infections that demonstrated over 90% efficacy in clinical trials registered with CTRI. - The natural formulation combines almond extract, coconut oil, eucalyptus oil, and chamomile processed through special extraction methods and has received patents in India and internationally. - The treatment addresses a significant medical need as fungal infections affect up to 61% of the population in some Indian states, with conventional steroid-based treatments facing growing drug resistance concerns. - Developed by Dr. Sunita Kumari and AYUSH-certified, the product aims to eliminate root causes of fungal overgrowth rather than masking symptoms like standard antifungals.
